“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

However, as Jabbour notes: “Although SGLT2 inhibitors also lead to weight loss, we do not know whether the loss of calories in the form of urinary glucose will lead to a compensatory increase in ...